{"data":{"id":"us-ok/okla.-stat.-tit.-63-63-2-803","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 63, § 63-2-803","heading":"Approved cannabidiol for use in clinical trials","body":"A. Clinical trials conducted pursuant to a statewide\n\ninvestigational new drug application established pursuant to the\n\nprovisions of this act shall only utilize cannabidiol which is:\n\n1. From an approved source; and\n\n2. Approved by the United States Food and Drug Administration\n\nto be used for treatment of a condition specified in an\n\ninvestigational new drug application.\n\nB. The principal investigator and any subinvestigator may\n\nreceive cannabidiol directly from an approved source or authorized\n\ndistributor for an approved source for use in the clinical trials.","path":["OK Code","Title 63"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os63.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"8436536f097bbd5bc65fedb7810f6684c5053d3c4400df19cb0d56381fdb26bc","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-63-63-2-802","next":"us-ok/okla.-stat.-tit.-63-63-2-804"},"notice":"GroundRules: Original legal text. Not legal advice."}